Document Detail


Adverse reaction; patent blue turning patient blue.
MedLine Citation:
PMID:  23203181     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The authors report a severe anaphylactic reaction to Patent Blue V dye used in sentinel node biopsy for lymphatic mapping during breast cancer surgery to stage the axilla. Patent Blue dye is the most widely used in the UK; however, adverse reactions have been reported with the blue dye previously. This case highlights that reactions may not always be immediately evident and to be vigilant in all patients that have undergone procedures using blue dye. If the patients are not responding appropriately particularly during an anaesthetic, one must always think of a possible adverse reaction to the dye. All surgical patients should give consent for adverse reactions to patent blue dye preoperatively. Alternative agents such as methylene blue are considered.
Authors:
Meera Joshi; Matthew Hart; Farid Ahmed; Sandy McPherson
Publication Detail:
Type:  Journal Article     Date:  2012-11-30
Journal Detail:
Title:  BMJ case reports     Volume:  2012     ISSN:  1757-790X     ISO Abbreviation:  BMJ Case Rep     Publication Date:  2012  
Date Detail:
Created Date:  2012-12-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101526291     Medline TA:  BMJ Case Rep     Country:  England    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Affiliation:
Buckinghamshire Healthcare NHS Trust, Bucks, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hibernoma of the thigh: a lipoma-like variant rare tumour mimicking soft tissue sarcoma.
Next Document:  Ascites as a manifestation of effusive-constrictive pericarditis in an African patient.